摘要
ObjectiveLong non-coding RNAs (lncRNAs) play a crucial role in non-small cell lung cancer (NSCLC). This study aimed to investigate the novel biomarker, lncRNA RP11-58O9.2, in patients with NSCLC.MethodsRP11-58O9.2 expression in NSCLC cells and tissues was detected by reverse transcription-quantitative polymerase chain reaction. Patient survival was analyzed in relation to RP11-58O9.2 expression levels. RP11-58O9.2 expression was knocked down and endogenous expression was verified in two NSCLC cell lines. Cell proliferation was then assessed by Cell Counting Kit-8 and colony-formation assays, and cell invasion and migration were assessed by Transwell and wound-healing assays, respectively. In vivo experiments were performed in mice, and the combination of RP11-58O9.2 and miR-6749-3p was predicted by miRanda.ResultsRP11-58O9.2 was highly expressed in NSCLC cell lines and tissues, and was associated with advanced stage, lymphatic metastasis, and differentiation group. High RP11-58O9.2 levels were also associated with shorter survival. RP11-58O9.2 knockdown inhibited the proliferation, invasion, and migration of lung cancer cells, and tumor growth in mouse xenografts in vivo. RP11-58O9.2 may target and regulate miR-6749-3p.ConclusionsLncRNA RP11-58O9.2 is associated with NSCLC prognosis and promotes lung cancer progression. Further studies are needed to investigate the mechanisms and the regulatory association between RP11-58O9.2 and miR-6749-3p.
学科与关键词
- Exosomal LncRNA RP5-977B1 as a novel minimally invasive biomarker for diagnosis and prognosis in non-small cell lung cancerMin, Ling; Zhu, Ting; Lv, Bo; An, Taixue; Zhang, Qichao; Shang, Yanyan; Yu, Zhiwu; Zheng, Lei; Wang, Qian*International Journal of Clinical Oncology, 2022, 27(6): 1013-1024.被引 15
- Construction of a 5 immune-related lncRNA-based prognostic model of NSCLC via bioinformaticsHuang, Ya-jie*; Huang, Chang-jieMedicine; analytical reviews of general medicine, neurology, psychiatry, dermatology, and pediatries, 2021, 100(37): e27222.被引 3
- Discovery of a novel linc01125 isoform in serum exosomes as a promising biomarker for NSCLC diagnosis and survival assessmentXian, Jianfeng; Zeng, Yuyuan; Chen, Shizhen; Lu, Liming; Liu, Li; Chen, Jinbin; Rao, Boqi; Zhao, Zhuxiang; Liu, Jun; Xie, Chenli; Zhu, Lingling; Zhang, Duo; Qiu, Fuman; Lu, Jiachun; Yang, Lei*Carcinogenesis, 2021, 42(6): 831-841.被引 12
